Multiple Endocrine Neoplasia
Personal experiences with cancer help clinicians ‘share the journey’ with patients
Christian S. Hinrichs, MD, is reluctant to give cancer credit for anything good.
GI symptoms negatively affect quality of life in multiple endocrine neoplasia type 2
More than half of patients with multiple endocrine neoplasia type 2, or MEN2, reported abdominal pain, diarrhea and constipation, and said gastrointestinal symptoms negatively affect their quality of life, according to survey data.
Elevenses with Mark Lewis, MD: Rare Cancers, On Becoming an Oncologist, and Hope
Mark A. Lewis, MD, is a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. In this episode, he talks about his path to becoming a GI oncologist and living with multiple endocrine neoplasia type 1.
Vandetanib confers clinical benefit for certain patients with medullary thyroid cancer
Vandetanib extended PFS among patients with symptomatic and progressive medullary thyroid cancer, according to results of a post hoc analysis of a randomized phase 3 study published in Journal of Clinical Oncology.
Pulmonary abnormalities, lung cysts seen in children, young adults with MEN2B
More than half of a cohort of children and young adults with multiple endocrine neoplasia type 2B had restrictive and obstructive lung abnormalities and 94% showed some degree of diminished lung function, NIH study data showed.